What is the appropriate surgical treatment for Tetralogy of Fallot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surgical Treatment of Tetralogy of Fallot

Complete surgical repair of Tetralogy of Fallot consists of VSD closure and relief of right ventricular outflow tract (RVOT) obstruction, with the surgical approach tailored to the anatomy of the RVOT and pulmonary valve annulus size. 1

Primary Complete Repair Components

The definitive surgical correction addresses two fundamental anatomic abnormalities 1:

  • VSD closure using either direct suture or patch technique 1
  • Relief of RVOT obstruction through resection of infundibular stenosis (muscle bundles) 1

RVOT Management Strategy

The extent of RVOT intervention depends critically on pulmonary annulus size 1, 2:

  • If pulmonary annulus is adequate: Simple infundibular muscle resection with valve preservation 1, 3
  • If pulmonary annulus is small: RV outflow patch augmentation or transannular patch placement (disrupts pulmonary valve integrity) 1
  • If anomalous coronary crosses RVOT: Extracardiac conduit from right ventricle to pulmonary artery 1
  • If pulmonary valve is abnormal: Pulmonary valvotomy or valve resection 1

Effort should be made to preserve the pulmonary valve during primary operation when performed in infancy, as this reduces long-term pulmonary regurgitation 1, 3

Additional Surgical Considerations

  • PFO or small ASD closure is routinely performed 1
  • Coronary anatomy must be assessed preoperatively to avoid interruption of anomalous vessels, particularly an anterior descending coronary crossing the RVOT 1

Timing of Surgery

The optimal timing balances patient symptoms against anatomic suitability 2:

  • Symptomatic neonates/young infants (<2-3 months): Either primary repair or initial palliation depending on pulmonary valve annulus Z-score 4, 2

    • Primary repair feasible with median age 68 days and weight 4.7 kg 4
    • Initial Z-score of pulmonary valve annulus is the only predictor of successful annulus preservation (odds ratio 1.715) 2
    • Annulus preservation probability <70% favors initial palliation 2
  • Standard repair timing: Most centers perform primary repair at 3-12 months of age 4

  • Earlier surgery does not increase morbidity or mortality and has potential advantages 3

Palliative Procedures (When Primary Repair Not Feasible)

Initial palliation options for high-risk young infants 4:

  • Right ventricular outflow tract stent (most common approach in UK practice) 4
  • Balloon pulmonary valvuloplasty 4
  • Modified Blalock-Taussig-Thomas shunt 4
  • Ductal stent 4
  • RVOT patch augmentation 4

Staged repair after palliation shows excellent one-year survival (95.7%) comparable to primary repair under 3 months (97.3%, P=0.55) 4

Surgical Approach Techniques

Contemporary surgical access prioritizes minimizing ventricular scarring 3:

  • Transatrial-transpulmonary approach (preferred when feasible): 52.2% of cases 3
  • Entirely transatrial: 10.6% of cases 3
  • Transatrial and transventricular: 31.8% of cases (when transannular patch required) 3
  • Homograft conduit: 5.3% of cases 3

The surgical technique should be adapted to the specific anatomy of the RVOT to achieve optimal results 3

Reintervention Surgery in Adults

Indications for Pulmonary Valve Replacement

Class I (Recommended) 5, 1:

  • Severe pulmonary regurgitation with cardiovascular symptoms 5
  • Severe pulmonary regurgitation with decreased exercise tolerance 1

Class IIa (Reasonable) 5, 1:

  • Severe PR with moderate-to-severe RV dysfunction 1
  • Severe PR with moderate-to-severe RV enlargement 1
  • Severe PR with symptomatic or sustained atrial/ventricular arrhythmias 1
  • Severe PR with moderate-to-severe tricuspid regurgitation 1

Pulmonary Valve Replacement Options

Surgical valve replacement choices 1:

  • Heterograft (porcine or pericardial bioprosthesis) - most common 1
  • Homograft 1
  • Mechanical valve - only in patients requiring warfarin for other indications (risk of late pannus formation) 1
  • Patch augmentation of pulmonary annulus for proper prosthetic sizing 1

Transcatheter pulmonary valve implantation (TPVI) has emerged as less invasive alternative with high procedural success 6:

  • SAPIEN 3 THV for degenerated conduits or surgical bioprostheses 6
  • Harmony TPV for native dilated RVOT after transannular patch 6

Additional Reintervention Procedures

Residual RVOT obstruction 1:

  • Resection of subvalvular obstruction and/or patch augmentation 1
  • Surgery reasonable when peak gradient >50 mmHg or RV/LV pressure ratio >0.7 1

Residual/recurrent VSD 1:

  • Closure indicated when left-to-right shunt >1.5:1 1
  • Direct suture or patch revision 1

Aortic valve/root pathology 1:

  • AVR (tissue or mechanical) for severe aortic regurgitation with symptoms or LV dysfunction 1
  • Ascending aorta replacement (tube graft or Bentall procedure) for dilatation 1

Arrhythmia management 1:

  • Maze procedure for atrial arrhythmias 1
  • EP testing and ablation for ventricular tachycardia (focus typically in RVOT between VSD patch and pulmonary annulus) 1
  • ICD placement for high-risk sudden death patients 1

Tricuspid valve 1:

  • Repair for significant regurgitation 1
  • Replacement for markedly abnormal valve 1

RVOT aneurysm/pseudoaneurysm: Resection and patch replacement 1

Critical Pitfalls to Avoid

  • Failure to assess coronary anatomy preoperatively risks interrupting anomalous coronary arteries during RVOT intervention 1
  • Overlooking pulmonary regurgitation - the murmur is short and quiet, frequently missed on clinical examination 1
  • Delaying pulmonary valve replacement until irreversible RV dysfunction occurs 7, 6
  • Ignoring residual hemodynamic lesions in patients presenting with arrhythmias or cardiomegaly 1

Outcomes

  • Long-term survival: 30-year survival ranges from 68.5% to 90.5% 7; 35-year survival approximately 85% 1
  • Sudden cardiac death risk: Approximately 2% per decade after repair 5, 1
  • Five-year freedom from reintervention: 76% after staged repair vs 88% after primary repair under 3 months 4

All operations should be performed by surgeons with training and expertise in congenital heart disease 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.